Recruiting Alzheimers Disease Studies in Berkeley
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or ...
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled...
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
This phase II/III trial compares whether cisplatin given weekly with radiation therapy is better tolerated than cisplatin given every three weeks with radiation therapy for the treatment of head and n...
About Alzheimers Disease Clinical Trials in Berkeley
Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.
There are currently 3 alzheimers disease clinical trials recruiting participants in Berkeley, CA. These studies are seeking a combined 8,910 participants. Research is being sponsored by American Society of Clinical Oncology, Eli Lilly and Company, NRG Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alzheimers Disease Clinical Trials in Berkeley — FAQ
Are there alzheimers disease clinical trials in Berkeley?
Yes, there are 3 alzheimers disease clinical trials currently recruiting in Berkeley, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Berkeley?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkeley research site will contact you about next steps.
Are clinical trials in Berkeley free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Berkeley studies also compensate for your time and travel.
What alzheimers disease treatments are being tested?
The 3 active trials in Berkeley are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.
Data updated March 2, 2026 from ClinicalTrials.gov